Cargando…

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) pose a significant global public health threat. Resistance among CRE is particularly complex, owing to numerous possible resistance mechanisms and broad definitions. We aimed to characterize the clinical and molecular profiles of CRE in the Sou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Cody A., So, Wonhee, Dallas, Steven S., Gawrys, Gerard, Benavides, Raymond, Aguilar, Samantha, Chen, Chang-Jui, Shurko, James F., Lee, Grace C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902696/ https://www.ncbi.nlm.nih.gov/pubmed/33643226 http://dx.doi.org/10.3389/fmicb.2020.623574

Ejemplares similares

118. Machine Learning Approaches to Predicting Treatment Outcomes for Carbapenem-Resistant Enterobacterales in a Region with High Prevalence of Non-Carbapenemase Producers
por: Black, Cody A, et al.
Publicado: (2021)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

Predominance of OXA-48 Carbapenemase-Producing Enterobacterales in a Moroccan Hospital
por: Belouad, El Mehdi, et al.
Publicado: (2023)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
por: Wielders, Cornelia C. H., et al.
Publicado: (2022)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales
por: Hussein, Khetam, et al.
Publicado: (2022)

Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales
por: Pudpong, Korawan, et al.
Publicado: (2022)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections
por: Burke, Elysia, et al.
Publicado: (2023)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe
por: Shortridge, Dee, et al.
Publicado: (2022)

ESBL Activity, MDR, and Carbapenem Resistance among Predominant Enterobacterales Isolated in 2019
por: Bandy, Altaf, et al.
Publicado: (2021)

Clonal Dissemination of Multiple Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Mediated by Multiple Plasmids in China
por: Li, Jun, et al.
Publicado: (2021)

Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE)
por: Fitzpatrick, Margaret A., et al.
Publicado: (2022)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
por: Bonnin, Rémy A., et al.
Publicado: (2023)

Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
por: Cahill, Niamh, et al.
Publicado: (2019)

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan
por: Habib, Amina, et al.
Publicado: (2022)

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa
por: Gill, Christian M., et al.
Publicado: (2023)

Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy
por: Alqahtani, Hajar, et al.
Publicado: (2022)

Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales
por: Marimuthu, Kalisvar, et al.
Publicado: (2022)

Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019–2021)
por: Sader, Helio S, et al.
Publicado: (2023)

Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
por: Räisänen, Kati, et al.
Publicado: (2020)

Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples
por: Sung, Gyung-Hye, et al.
Publicado: (2022)

Paradoxical consequences of wastewater interventions targeting carbapenemase-producing Enterobacterales
por: Lehman, David, et al.
Publicado: (2023)

2760. Fecal Microbiota Transplantation for Decolonization of Carbapenemase-Producing Enterobacterales
por: Davido, Benjamin, et al.
Publicado: (2023)

A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Enterobacterales Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48
por: Duong, Tran Thi Thuy, et al.
Publicado: (2022)

Carbapenemase detection by NG-Test CARBA 5—a rapid immunochromatographic assay in carbapenem-resistant Enterobacterales diagnosis
por: Zhu, Ying, et al.
Publicado: (2021)

1441. Using Carbapenem Resistance Levels to Discriminate Between Carbapenemase Producing and Non-Carbapenemase Producing Carbapenem Resistant Enterobacteriaceae
por: Koehne, William J, et al.
Publicado: (2020)

1218. Activity of Meropenem-Vaborbactam and Comparator Agents Against Carbapenemase-Negative, Carbapenem-Resistant Enterobacterales from US Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2021)

Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase
por: Abdelaziz, Neveen A.
Publicado: (2022)

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19
por: Farfour, Eric, et al.
Publicado: (2020)

Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2021)

Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016–2021
por: Yu, Haiyang, et al.
Publicado: (2022)

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
por: Ramette, Alban, et al.
Publicado: (2021)

＜Editors’ Choice＞ Multicenter survey for carbapenemase-producing Enterobacterales in central Japan
por: Hara, Yuki, et al.
Publicado: (2022)

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Carbapenem-Resistant Gram-Negative Bacilli Causing Ventilator Associated Pneumonia: Study of MASTDISCS Combi Carba Plus for Detection of Carbapenemase Producing Enterobacterales
por: Hegazy, Eman E, et al.
Publicado: (2022)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2019)

Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis
por: Tadese, Bekana K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a708u0itt6gfg13n6p33c5tl2g